Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|July 13, 2023
An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical modelsAakanksha Dixit, Hannah S Savage, Judith M GreerInternational Journal of Molecular Sciences|October 14, 2017
Novel Therapeutics for Multiple Sclerosis Designed by Parasitic WormsAakanksha Dixit, Akane Tanaka, Judith M Greer, et al.Proceedings of the National Academy of Sciences of the United States of America|January 7, 2011
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral driftJason R Cantor, Tae Hyeon Yoo, Aakanksha Dixit, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2013
Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosisNiannian Ji, Animesh Somanaboeina, Aakanksha Dixit, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2025
An immunoregulatory amphipathic peptide derived from Fasciola hepatica helminth defense molecule (FhHDM-1.C2) exhibits potent biotherapeutic activity in a murine model of multiple sclerosisRichard Lalor, Akane Tanaka, Jenna Shiels, et al.Scientific Reports|November 25, 2016
A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosisMaria E Lund, Judith Greer, Aakanksha Dixit, et al.Pageof 1